open91 visninger
Singapore
SingaporeEspressoLab Venture Boost Program
A data‑driven, equity‑free venture boost program for Singapore‑based biotech and healthtech startups, helping them become investment‑ready and expand into Europe through 1:1 strategic sessions, clinical and regulatory expertise, and access to Angelini Ventures' global network.
Hvem kan ansøge
Singapore‑based biomedical or healthtech startups with innovation backed by strong scientific or technological foundations and proprietary, research‑based IP, at Seed to Series A stage, and with ambition to expand into Europe within the next 2–3 years.Fordele og Goder
- 1:1 strategic sessions
- Advisor input
- Investment‑readiness report
- Access to Angelini Ventures' global network of advisors, pharma and biotech partners, and international investors
- Clinical and regulatory expertise
- Data‑driven Intelligence Hub for benchmarking
- Targeted introductions to advisors, investors or Startup SG support
Nøglekontakter
- LinkedIn ↗
Elia Stupka
Managing Director
- LinkedIn ↗
Tanja Dowe
Managing Director
- LinkedIn ↗
Regina Hodits
Managing Director
- LinkedIn ↗
Paolo Di Giorgio
CEO and Managing Director
Kilder
Links brugt af AI til at indsamle information om dette legat.
- espressolab.health/home ↗
- www.linkedin.com/posts/eliastupka_singapore-biotech-medtech-activity-74519404762… ↗
- www.linkedin.com/posts/espressolab-health_singapore-founders-this-ones-for-you-a… ↗
- startupintros.com/orgs/angelini-ventures ↗
- www.sginnovate.com/event/bridging-singapore-europe-espressolab-launch ↗
- firstwordpharma.com/story/6543368 ↗
- angeliniventures.com/ ↗
- www.angeliniventures.com/fellowship-program/ ↗